In this episode, Caleb Greer is back to discuss one of the hottest current topics, GLP-1 agonists! We talk about the classic semaglutide as well as deep dive into the new darling of weight loss and blood sugar regulation/type 2 diabetes, Tirzepatide (Mounjaro). If you have been wondering how dosing translates, what results can be expected, the risks and how side effects differ, or if you are a good candidate, this episode will be a great precursor to speaking to your provider!

Read More